Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2007; 13(4): 628-632
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.628
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.628
Table 1 A age and sex, duration of treatment, and peak liver test values in patients with different types of DILD
| Total | Hepatocelluar | Cholestatic | Mixed | |
| Number | 265 | 191 | 51 | 23 |
| Age (x ± s) | 48.6 ± 13.7 | 47.8 ± 13.8 | 52.1 ± 13.0 | 47.3 ± 14.0 |
| Sex (F/M) | 140/125 | 100/91 | 27/24 | 13/10 |
| Duration of treatment (d) | 25.9 (1-121) | 24.6 (1-120) | 31.4 (8-121) | 21.7 (1-47) |
| Total bilirubin (μmol/L) | 95.7 (7-701) | 67.5 (7-701) | 236 (11-615) | 105.5 (14-630) |
| Direct bilirubin (μmol/L) | 49.4 (2-461) | 31.8 (2-338) | 126.8 (3-461) | 47.5 (3.3-281) |
| Total protein (g/L) | 66.9 ± 9.4 | 67.7 ± 9.6 | 63.3 ± 8.8 | 68.1 ± 8.0 |
| Albumin (g/L) | 38.1 ± 7.3 | 39.1 ± 6.9 | 34.9 ± 8.3 | 36.4 ± 6.2 |
| ALT (U/L) | 351.5 (13-2652) | 313.8 (20-2652) | 123.4 (13-1079) | 557 (92-1600) |
| AST (U/L) | 230.1 (18-1925) | 282.9 (19-1925) | 111.8 (18-1165) | 393 (48-1553) |
| ALP (U/L) | 141.8 (51-1165) | 69.6 (51-370) | 117.8 (70-1165) | 318.8 (147-801) |
| GGT (U/L) | 200.7 (16-3102) | 112.9 (17-788) | 254 (16-3102) | 241 (87-969) |
- Citation: Li B, Wang Z, Fang JJ, Xu CY, Chen WX. Evaluation of prognostic markers in severe drug-induced liver disease. World J Gastroenterol 2007; 13(4): 628-632
- URL: https://www.wjgnet.com/1007-9327/full/v13/i4/628.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i4.628